Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: Results of long-term follow-up

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 4, 2012, Pages 559-565

  Freixa, Xavier ^a   Almasood, Ali S ^a   Khan, Sohail Q ^a   Wainstein, Rodrigo ^a   Osherov, Azriel ^a   MacKie, Karen ^a   Seidelin, Peter H ^a   Džavík, Vladimír ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

drug eluting stents; in stent restenosis; stent fracture

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IATROGENIC DISEASE; IN-STENT RESTENOSIS; MALE; OUTCOME ASSESSMENT; PREDICTION; RISK FACTOR; RISK REDUCTION; STENT FRACTURE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; PACLITAXEL; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857389355     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23031     Document Type: Article

References (25)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323. (Pubitemid 37186209)
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231. (Pubitemid 38067635)
3. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130. (Pubitemid 40617065)
4. Shaikh F, Maddikunta R, Djelmami-Hani M, Solis J, Allaqaband S, Bajwa T,. Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis? Catheter Cardiovasc Interv 2008; 71: 614-618. (Pubitemid 351550399)
5. Sianos G, Hofma S, Ligthart JM, Saia F, Hoye A, Lemos PA, Serruys PW,. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv 2004; 61: 111-116. (Pubitemid 38036800)
6. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, Hoye A, Degertekin M, Daemen J, McFadden E, et al. Coronary restenosis after sirolimus-eluting stent implantation: Morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003; 108: 257-260. (Pubitemid 36899012)
7. Aoki J, Nakazawa G, Tanabe K, Hoye A, Yamamoto H, Nakayama T, Onuma Y, Higashikuni Y, Otsuki S, Yagishita A, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 2007; 69: 380-386. (Pubitemid 46339279)
8. Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R,. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol 2009; 54: 1924-1931.
9. Canan T, Lee MS,. Drug-eluting stent fracture: Incidence, contributing factors, and clinical implications. Catheter Cardiovasc Interv 2010; 75: 237-245.
10. Kim HS, Kim YH, Lee SW, Park DW, Lee CW, Hong MK, Park SW, Ko JK, Park JH, Lee JH, et al. Incidence and predictors of drug-eluting stent fractures in long coronary disease. Int J Cardiol 2009; 133: 354-358.
11. Yamada KP, Koizumi T, Yamaguchi H, Kaneda H, Bonneau HN, Honda Y, Fitzgerald PJ,. Serial angiographic and intravascular ultrasound analysis of late stent strut fracture of sirolimus-eluting stents in native coronary arteries. Int J Cardiol 2008; 130: 255-259.
12. Okumura M, Ozaki Y, Ishii J, Kan S, Naruse H, Matsui S, Ishikawa M, Hattori K, Gochi T, Nakano T, et al. Restenosis and stent fracture following sirolimus-eluting stent (SES) implantation. Circ J 2007; 71: 1669-1677.
13. Chung WS, Park CS, Seung KB, Kim PJ, Lee JM, Koo BK, Jang YS, Yang JY, Yoon JH, Kim DI, et al. The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation. Int J Cardiol 2008; 125: 325-331.
14. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, Takarada S, Kitabata H, Tanimoto T, Mizukoshi M, et al. Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation. Circ J 2009; 73: 2036-2041.
15. Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S,. Stent fracture associated with drug-eluting stents: Clinical characteristics and implications. Catheter Cardiovasc Interv 2007; 69: 387-394. (Pubitemid 46339280)
16. Lee SE, Jeong MH, Kim IS, Ko JS, Lee MG, Kang WY, Kim SH, Sim DS, Park KH, Yoon NS, et al. Clinical outcomes and optimal treatment for stent fracture after drug-eluting stent implantation. J Cardiol 2009; 53: 422-428.
17. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W, Shim BS,. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol 2007; 100: 627-630. (Pubitemid 47223137)
18. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, Ishiki R, Inagaki H, Toyama J, Yokota M, Murohara T,. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol 2009; 133: 321-326.
19. Freed MS, Safian RD,. Proximal vessel tortuosity and angulated lesions. In:, Safian RD, Freed MS,. The Manual of Interventional Cardiology, 3rd ed. Royal Oak, Michigan, Physician's Press; 2001. pp 237-243.
20. Watanabe T, Tamura A, Miyamoto K, Kadota J,. Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture. Int J Cardiol 2010; 140: e12-e13.
21. Yang TH, Kim DI, Park SG, Seo JS, Cho HJ, Seol SH, Kim SM, Kim DK, Kim DS,. Clinical characteristics of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol 2009; 131: 212-216.
22. Tizon-Marcos H, De Larochelliere R, Larose E,. Breakpoint: Left main stent fractureâ-Review of the literature. J Interv Cardiol 2009; 22: 362-367.
23. Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP, Snead D, Mauri L, Cutlip DE, Sousa E,. Long-term clinical outcomes with sirolimus-eluting coronary stents: Five-year results of the RAVEL trial. J Am Coll Cardiol 2007; 50: 1299-1304. (Pubitemid 47454687)
24. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794. (Pubitemid 37022118)
25. Sousa A, Costa JR Jr, Moreira AC, Cano M, Maldonado G, Costa RA, Pavanello R, Romano ER, Campos C, Haddad N, et al. Long-term clinical outcomes of the drug-eluting stents in the real world (DESIRE) registry. J Interv Cardiol 2008; 21: 307-314. (Pubitemid 352033299)